drugset / Trial / NCT00349024

Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer

NCT00349024 ↗

Open-labelSupportive care

Summary

RATIONALE: Polyvinylpyrrolidone-sodium hyaluronate gel may lessen the pain of oral mucositis, or mouth sores, in patients undergoing treatment for cancer. PURPOSE: This clinical trial is studying how well polyvinylpyrrolidone-sodium hyaluronate gel works in reducing pain from oral mucositis in young patients with cancer.

Timeline

Start
2005-07
Primary completion
2009-12
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject polyvinylpyrrolidone-sodium hyaluronate gel Unknown — Oral